Keratoconus is the leading cause of corneal transplantation in young people. It has 2% prevalence with a constant increase globally.
The emotional and economic burden of keratoconus deeply influences the quality of life of young patients and their families.
Regensight has the primary scope of addressing patients’ concerns and providing the eye surgeons cutting-edge technologies to elevate the standard of care for improving vision and quality of life in keratoconus.